{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:53:34Z","timestamp":1791359614274,"version":"4.3.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T00:00:00Z","timestamp":1787961600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T00:00:00Z","timestamp":1787961600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s11060-026-05776-0","type":"journal-article","created":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T09:10:33Z","timestamp":1787994633000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Survival and hematologic toxicity after whole-brain radiotherapy, photon craniospinal irradiation, and proton craniospinal irradiation for solid-tumor leptomeningeal disease: a systematic review"],"prefix":"10.1007","volume":"179","author":[{"given":"Mishaal","family":"Munir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kavita","family":"Sehrawat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanan","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minesh P.","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan. T.","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rupesh","family":"Kotecha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,29]]},"reference":[{"issue":"5","key":"5776_CR1","doi-asserted-by":"publisher","first-page":"101624","DOI":"10.1016\/j.esmoop.2023.101624","volume":"8","author":"E Le Rhun","year":"2023","unstructured":"Le Rhun E, Weller M, van den Bent M, Brandsma D, Furtner J, Rud\u00e0 R et al (2023) Leptomeningeal metastasis from solid tumours: EANO-ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. ESMO Open 8(5):101624","journal-title":"ESMO Open"},{"issue":"10","key":"5776_CR2","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1093\/neuonc\/noae103","volume":"26","author":"JA Wilcox","year":"2024","unstructured":"Wilcox JA, Chukwueke UN, Ahn MJ, Aizer AA, Bale TA, Brandsma D et al (2024) Leptomeningeal metastases from solid tumors: A Society for Neuro-Oncology and American Society of Clinical Oncology consensus review on clinical management and future directions. Neuro Oncol 26(10):1781\u20131804","journal-title":"Neuro Oncol"},{"issue":"1","key":"5776_CR3","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1002\/cncr.30911","volume":"124","author":"N Wang","year":"2018","unstructured":"Wang N, Bertalan MS, Brastianos PK (2018) Leptomeningeal metastasis from systemic cancer: Review and update on management. Cancer 124(1):21\u201335","journal-title":"Cancer"},{"issue":"Suppl 4","key":"5776_CR4","first-page":"S265","volume":"4","author":"E Le Rhun","year":"2013","unstructured":"Le Rhun E, Taillibert S, Chamberlain MC (2013) Carcinomatous meningitis: Leptomeningeal metastases in solid tumors. Surg Neurol Int 4(Suppl 4):S265\u2013S288","journal-title":"Surg Neurol Int"},{"issue":"6","key":"5776_CR5","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1097\/CCO.0b013e32833de986","volume":"22","author":"MC Chamberlain","year":"2010","unstructured":"Chamberlain MC (2010) Leptomeningeal metastasis. Curr Opin Oncol 22(6):627\u2013635","journal-title":"Curr Opin Oncol"},{"key":"5776_CR6","doi-asserted-by":"publisher","first-page":"800053","DOI":"10.3389\/fonc.2021.800053","volume":"11","author":"SD Ferguson","year":"2021","unstructured":"Ferguson SD, Fomchenko EI, Guerrieri RA, Glitza Oliva IC (2021) Challenges and Advances in Diagnosis and Treatment of Leptomeningeal Disease (LMD). Front Oncol 11:800053","journal-title":"Front Oncol"},{"issue":"3","key":"5776_CR7","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1093\/neuonc\/noae267","volume":"27","author":"LB Nabors","year":"2025","unstructured":"Nabors LB, Hattangadi-Gluth J, Horbinski C, Portnow J (2025) NCCN CNS Tumor Guidelines Update for 2024. Neuro Oncol 27(3):595\u2013596","journal-title":"Neuro Oncol"},{"issue":"2","key":"5776_CR8","doi-asserted-by":"publisher","first-page":"101377","DOI":"10.1016\/j.adro.2023.101377","volume":"9","author":"AB Barbour","year":"2024","unstructured":"Barbour AB, Kotecha R, Lazarev S, Palmer JD, Robinson T, Yerramilli D et al (2024) Radiation Therapy in the Management of Leptomeningeal Disease From Solid Tumors. Adv Radiat Oncol 9(2):101377","journal-title":"Adv Radiat Oncol"},{"issue":"5","key":"5776_CR9","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1200\/JCO.21.02314","volume":"40","author":"MA Vogelbaum","year":"2022","unstructured":"Vogelbaum MA, Brown PD, Messersmith H, Brastianos PK, Burri S, Cahill D et al (2022) Treatment for Brain Metastases: ASCO-SNO-ASTRO Guideline. J Clin Oncol 40(5):492\u2013516","journal-title":"J Clin Oncol"},{"issue":"4","key":"5776_CR10","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.prro.2022.02.003","volume":"12","author":"V Gondi","year":"2022","unstructured":"Gondi V, Bauman G, Bradfield L, Burri SH, Cabrera AR, Cunningham DA et al (2022) Radiation Therapy for Brain Metastases: An ASTRO Clinical Practice Guideline. Pract Radiat Oncol 12(4):265\u2013282","journal-title":"Pract Radiat Oncol"},{"key":"5776_CR11","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.3389\/fonc.2019.01224","volume":"9","author":"SM Buszek","year":"2019","unstructured":"Buszek SM, Chung C (2019) Radiotherapy in Leptomeningeal Disease: A Systematic Review of Randomized and Non-randomized Trials. Front Oncol 9:1224","journal-title":"Front Oncol"},{"issue":"10","key":"5776_CR12","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1007\/s12094-021-02615-8","volume":"23","author":"L Maillie","year":"2021","unstructured":"Maillie L, Salgado LR, Lazarev S (2021) A systematic review of craniospinal irradiation for leptomeningeal disease: past, present, and future. Clin Transl Oncol 23(10):2109\u20132119","journal-title":"Clin Transl Oncol"},{"issue":"1","key":"5776_CR13","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1093\/neuonc\/noaa152","volume":"23","author":"TJ Yang","year":"2021","unstructured":"Yang TJ, Wijetunga NA, Yamada J, Wolden S, Mehallow M, Goldman DA et al (2021) Clinical trial of proton craniospinal irradiation for leptomeningeal metastases. Neuro Oncol 23(1):134\u2013143","journal-title":"Neuro Oncol"},{"issue":"2","key":"5776_CR14","doi-asserted-by":"publisher","first-page":"101697","DOI":"10.1016\/j.adro.2024.101697","volume":"10","author":"K Lam","year":"2025","unstructured":"Lam K, Nasr LF, Andersen CR, Marqueen KE, Li J, Wang C et al (2025) Early Outcomes from Proton Craniospinal Irradiation for Leptomeningeal Metastasis From Solid Tumors. Adv Radiat Oncol 10(2):101697","journal-title":"Adv Radiat Oncol"},{"issue":"11","key":"5776_CR15","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1001\/jamaoncol.2025.3007","volume":"11","author":"JT Yang","year":"2025","unstructured":"Yang JT, Yerramilli D, Pentsova E, Wolden S, Young RJ, Correa DD et al (2025) Proton Craniospinal Irradiation for Patients With Leptomeningeal Metastasis: A Randomized Clinical Trial. JAMA Oncol 11(11):1293\u20131301","journal-title":"JAMA Oncol"},{"key":"5776_CR16","doi-asserted-by":"crossref","unstructured":"Frechette KM, Breen WG, Brown PD, Sener UT, Webb LM, Routman DM et al (2024) Radiotherapy and systemic treatment for leptomeningeal disease. Biomed 12(8)","DOI":"10.3390\/biomedicines12081792"},{"key":"5776_CR17","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71","journal-title":"BMJ"},{"key":"5776_CR18","unstructured":"Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (2024) Cochrane handbook for systematic reviews of interventions. Version 6.5. Cochrane"},{"issue":"2","key":"5776_CR19","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1007\/s00066-011-0025-8","volume":"188","author":"C Gani","year":"2012","unstructured":"Gani C, M\u00fcller AC, Eckert F, Schroeder C, Bender B, Pantazis G et al (2012) Outcome after whole brain radiotherapy alone in intracranial leptomeningeal carcinomatosis from solid tumors. Strahlenther Onkol 188(2):148\u2013153","journal-title":"Strahlenther Onkol"},{"issue":"5","key":"5776_CR20","doi-asserted-by":"publisher","first-page":"e449","DOI":"10.1111\/ajco.12597","volume":"13","author":"M Sakaguchi","year":"2017","unstructured":"Sakaguchi M, Maebayashi T, Aizawa T, Ishibashi N, Saito T (2017) Patient outcomes of whole brain radiotherapy for brain metastases versus leptomeningeal metastases: A retrospective study. Asia Pac J Clin Oncol 13(5):e449\u2013e57","journal-title":"Asia Pac J Clin Oncol"},{"issue":"2","key":"5776_CR21","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s11060-013-1228-x","volume":"115","author":"C Du","year":"2013","unstructured":"Du C, Hong R, Shi Y, Yu X, Wang J (2013) Leptomeningeal metastasis from solid tumors: a single center experience in Chinese patients. J Neurooncol 115(2):285\u2013291","journal-title":"J Neurooncol"},{"key":"5776_CR22","doi-asserted-by":"publisher","unstructured":"Katano A Overall survival following whole-brain radiotherapy for brain and leptomeningeal metastases from solid tumors. Tzu Chi Med J 9900. https:\/\/doi.org\/10.4103\/tcmj.TCMJ-D-25-00075","DOI":"10.4103\/tcmj.TCMJ-D-25-00075"},{"issue":"2","key":"5776_CR23","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/BF02327385","volume":"6","author":"WT Sause","year":"1988","unstructured":"Sause WT, Crowley J, Eyre HJ, Rivkin SE, Pugh RP, Quagliana JM et al (1988) Whole brain irradiation and intrathecal methotrexate in the treatment of solid tumor leptomeningeal metastases\u2013a Southwest Oncology Group study. J Neurooncol 6(2):107\u2013112","journal-title":"J Neurooncol"},{"issue":"12","key":"5776_CR24","doi-asserted-by":"publisher","first-page":"3237","DOI":"10.1093\/neuonc\/noaf183","volume":"27","author":"Y Pi\u00f1a","year":"2025","unstructured":"Pi\u00f1a Y, Law V, Sahebjam S, Tran N, Siddarajappa N, Li J et al (2025) Phase IB study of Avelumab and whole brain radiotherapy in patients with leptomeningeal disease from solid tumors: Results and molecular analyses. Neuro Oncol 27(12):3237\u20133249","journal-title":"Neuro Oncol"},{"issue":"31","key":"5776_CR25","doi-asserted-by":"publisher","first-page":"e21333","DOI":"10.1097\/MD.0000000000021333","volume":"99","author":"Y Okada","year":"2020","unstructured":"Okada Y, Abe T, Shinozaki M, Tanaka A, Kobayashi M, Hiromichi G et al (2020) Evaluation of imaging findings and prognostic factors after whole-brain radiotherapy for carcinomatous meningitis from breast cancer: A retrospective analysis. Med (Baltim) 99(31):e21333","journal-title":"Med (Baltim)"},{"issue":"1","key":"5776_CR26","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s11060-018-2790-z","volume":"138","author":"A Niwi\u0144ska","year":"2018","unstructured":"Niwi\u0144ska A, Pogoda K, Michalski W, Kunkiel M, Jagie\u0142\u0142o-Gruszfeld A (2018) Determinants of prolonged survival for breast cancer patient groups with leptomeningeal metastasis (LM). J Neurooncol 138(1):191\u2013198","journal-title":"J Neurooncol"},{"issue":"1","key":"5776_CR27","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.clbc.2014.07.004","volume":"15","author":"A Niwi\u0144ska","year":"2015","unstructured":"Niwi\u0144ska A, Rudnicka H, Murawska M (2015) Breast cancer leptomeningeal metastasis: the results of combined treatment and the comparison of methotrexate and liposomal cytarabine as intra-cerebrospinal fluid chemotherapy. Clin Breast Cancer 15(1):66\u201372","journal-title":"Clin Breast Cancer"},{"issue":"2","key":"5776_CR28","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/s11060-013-1175-6","volume":"114","author":"S Yust-Katz","year":"2013","unstructured":"Yust-Katz S, Garciarena P, Liu D, Yuan Y, Ibrahim N, Yerushalmi R et al (2013) Breast cancer and leptomeningeal disease (LMD): hormone receptor status influences time to development of LMD and survival from LMD diagnosis. J Neurooncol 114(2):229\u2013235","journal-title":"J Neurooncol"},{"key":"5776_CR29","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.breast.2017.07.015","volume":"36","author":"B Kingston","year":"2017","unstructured":"Kingston B, Kayhanian H, Brooks C, Cox N, Chaabouni N, Redana S et al (2017) Treatment and prognosis of leptomeningeal disease secondary to metastatic breast cancer: A single-centre experience. Breast 36:54\u201359","journal-title":"Breast"},{"issue":"2","key":"5776_CR30","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1097\/JTO.0b013e3182398e4f","volume":"7","author":"PG Morris","year":"2012","unstructured":"Morris PG, Reiner AS, Szenberg OR, Clarke JL, Panageas KS, Perez HR et al (2012) Leptomeningeal metastasis from non-small cell lung cancer: survival and the impact of whole brain radiotherapy. J Thorac Oncol 7(2):382\u2013385","journal-title":"J Thorac Oncol"},{"issue":"2","key":"5776_CR31","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s11060-016-2179-9","volume":"129","author":"Y Ozdemir","year":"2016","unstructured":"Ozdemir Y, Yildirim BA, Topkan E (2016) Whole brain radiotherapy in management of non-small-cell lung carcinoma associated leptomeningeal carcinomatosis: evaluation of prognostic factors. J Neurooncol 129(2):329\u2013335","journal-title":"J Neurooncol"},{"issue":"12","key":"5776_CR32","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1097\/JTO.0000000000000669","volume":"10","author":"BC Liao","year":"2015","unstructured":"Liao BC, Lee JH, Lin CC, Chen YF, Chang CH, Ho CC et al (2015) Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors for Non-Small-Cell Lung Cancer Patients with Leptomeningeal Carcinomatosis. J Thorac Oncol 10(12):1754\u20131761","journal-title":"J Thorac Oncol"},{"issue":"4","key":"5776_CR33","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1111\/1759-7714.12188","volume":"6","author":"Q Xu","year":"2015","unstructured":"Xu Q, Chen X, Qian D, Wang Y, Meng S, Liu H et al (2015) Treatment and prognostic analysis of patients with leptomeningeal metastases from non-small cell lung cancer. Thorac Cancer 6(4):407\u2013412","journal-title":"Thorac Cancer"},{"issue":"11","key":"5776_CR34","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1016\/j.jtho.2016.06.029","volume":"11","author":"YS Li","year":"2016","unstructured":"Li YS, Jiang BY, Yang JJ, Tu HY, Zhou Q, Guo WB et al (2016) Leptomeningeal Metastases in Patients with NSCLC with EGFR Mutations. J Thorac Oncol 11(11):1962\u20131969","journal-title":"J Thorac Oncol"},{"issue":"7","key":"5776_CR35","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1007\/s10147-020-01668-z","volume":"25","author":"Y Hirano","year":"2020","unstructured":"Hirano Y, Konishi K, Ejima Y (2020) Utility of whole brain radiation therapy for leptomeningeal carcinomatosis. Int J Clin Oncol 25(7):1432\u20131439","journal-title":"Int J Clin Oncol"},{"issue":"1","key":"5776_CR36","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1186\/s13014-020-01627-y","volume":"15","author":"J Zhen","year":"2020","unstructured":"Zhen J, Wen L, Lai M, Zhou Z, Shan C, Li S et al (2020) Whole brain radiotherapy (WBRT) for leptomeningeal metastasis from NSCLC in the era of targeted therapy: a retrospective study. Radiat Oncol 15(1):185","journal-title":"Radiat Oncol"},{"issue":"1","key":"5776_CR37","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1186\/s13014-019-1376-z","volume":"14","author":"W Yan","year":"2019","unstructured":"Yan W, Liu Y, Li J, Han A, Kong L, Yu J et al (2019) Whole brain radiation therapy does not improve the overall survival of EGFR-mutant NSCLC patients with leptomeningeal metastasis. Radiat Oncol 14(1):168","journal-title":"Radiat Oncol"},{"issue":"2","key":"5776_CR38","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1097\/JTO.0b013e3182773f21","volume":"8","author":"SJ Lee","year":"2013","unstructured":"Lee SJ, Lee JI, Nam DH, Ahn YC, Han JH, Sun JM et al (2013) Leptomeningeal carcinomatosis in non-small-cell lung cancer patients: impact on survival and correlated prognostic factors. J Thorac Oncol 8(2):185\u2013191","journal-title":"J Thorac Oncol"},{"issue":"5","key":"5776_CR39","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1007\/s10585-023-10225-7","volume":"40","author":"H Oyoshi","year":"2023","unstructured":"Oyoshi H, Hirata H, Hirano Y, Zenda S, Zhou Y, Tomizawa K et al (2023) Prognostic impact of EGFR\/ALK alterations in leptomeningeal metastasis from lung adenocarcinoma treated with whole-brain radiotherapy. Clin Exp Metastasis 40(5):407\u2013413","journal-title":"Clin Exp Metastasis"},{"issue":"Supplement5","key":"5776_CR40","first-page":"v100","volume":"27","author":"G Lamanilao","year":"2025","unstructured":"Lamanilao G, Hostler B, Le T, Austin T, Piccioni D, Schulte J et al (2025) RADT-37. A comparative study of proton vs photon volumetric modulated arc therapy craniospinal irradiation for solid tumor leptomeningeal carcinomatosis. Neuro-Oncol 27(Supplement5):v100\u2013v","journal-title":"Neurooncology"},{"issue":"4","key":"5776_CR41","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/PL00002398","volume":"177","author":"B Hermann","year":"2001","unstructured":"Hermann B, H\u00fcltenschmidt B, Sautter-Bihl ML (2001) Radiotherapy of the neuroaxis for palliative treatment of leptomeningeal carcinomatosis. Strahlenther Onkol 177(4):195\u2013199","journal-title":"Strahlenther Onkol"},{"key":"5776_CR42","doi-asserted-by":"publisher","first-page":"789","DOI":"10.2147\/CMAR.S182154","volume":"11","author":"RA El Shafie","year":"2019","unstructured":"El Shafie RA, B\u00f6hm K, Weber D, Lang K, Schlaich F, Adeberg S et al (2019) Outcome and prognostic factors following palliative craniospinal irradiation for leptomeningeal carcinomatosis. Cancer Manag Res 11:789\u2013801","journal-title":"Cancer Manag Res"},{"issue":"1","key":"5776_CR43","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1186\/s12885-020-06984-1","volume":"20","author":"M Devecka","year":"2020","unstructured":"Devecka M, Duma MN, Wilkens JJ, Kampfer S, Borm KJ, M\u00fcnch S et al (2020) Craniospinal irradiation(CSI) in patients with leptomeningeal metastases: risk-benefit-profile and development of a prognostic score for decision making in the palliative setting. BMC Cancer 20(1):501","journal-title":"BMC Cancer"},{"issue":"5","key":"5776_CR44","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1093\/jrr\/rrae059","volume":"65","author":"K Takeda","year":"2024","unstructured":"Takeda K, Umezawa R, Yamamoto T, Takahashi N, Jingu K (2024) Craniospinal irradiation for leptomeningeal metastasis of solid tumors: survival analysis and prognostic factors. J Radiat Res 65(5):667\u2013675","journal-title":"J Radiat Res"},{"issue":"2","key":"5776_CR45","doi-asserted-by":"publisher","first-page":"e242","DOI":"10.1016\/j.ijrobp.2024.07.542","volume":"120","author":"E Keit","year":"2024","unstructured":"Keit E, Peterson J, Johnstone PAS, Robinson TJ, Figura NB (2024) Modern Photon-Based Craniospinal Irradiation in Leptomeningeal Disease. Int J Radiat Oncol Biol Phys 120(2):e242","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"6","key":"5776_CR46","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.prro.2025.06.010","volume":"15","author":"O Gal","year":"2025","unstructured":"Gal O, Yang JT, Kotecha R (2025) Current Status of Proton Craniospinal Irradiation for Solid Tumor Leptomeningeal Disease. Pract Radiat Oncol 15(6):524\u2013527","journal-title":"Pract Radiat Oncol"},{"issue":"1","key":"5776_CR47","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s13014-025-02618-7","volume":"20","author":"F Ehret","year":"2025","unstructured":"Ehret F, Yuan AM, Marciscano AE, Zieminski S, Leland PA, Khandekar MJ et al (2025) Early experience with proton craniospinal irradiation in adult patients with leptomeningeal disease. Radiat Oncol 20(1):61","journal-title":"Radiat Oncol"},{"issue":"3","key":"5776_CR48","doi-asserted-by":"publisher","first-page":"101424","DOI":"10.1016\/j.adro.2023.101424","volume":"9","author":"HK Perlow","year":"2024","unstructured":"Perlow HK, Matsui JK, Ewing A, Cadieux C, Dibs K, Upadhyay R et al (2024) Volumetric Modulated Arc Therapy Craniospinal Irradiation Utilizing a Vertebral Body Sparing Approach: An Alternative Approach to Improve Access and Minimize Toxicity. Adv Radiation Oncol 9(3):101424","journal-title":"Adv Radiation Oncol"},{"key":"5776_CR49","unstructured":"ClinicalTrials.gov. (2026) Testing proton craniospinal radiation therapy versus the usual radiation therapy for leptomeningeal metastasis, RADIATE-LM Trial. Available from: https:\/\/clinicaltrials.gov\/study\/NCT06500481"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-026-05776-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11060-026-05776-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-026-05776-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:34:52Z","timestamp":1791358492000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11060-026-05776-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,29]]},"references-count":49,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["5776"],"URL":"https:\/\/doi.org\/10.1007\/s11060-026-05776-0","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,29]]},"assertion":[{"value":"3 August 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Institutional review board approval and informed consent were not required because this study is a systematic review of previously published literature and did not involve individual-level patient data.","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"64"}}